PRE 14A

FORM PRE 14A

Company: ZEVRA THERAPEUTICS, INC.
Filed: September 25, 2020
Period of Report: September 25, 2020
Accession Number: 0001437749-20-020263

View Document ↗ View on SEC.gov ↗